Education
About Us
Working with TipRanks
Follow Us
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
Earnings Data
Report Date
Nov 11, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.23Last Year’s EPS
-0.28Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, new customer acquisitions, and a landmark partnership with AstraZeneca, reflecting positive business momentum. However, challenges remain with BioPharma headwinds, increased operating expenses, and regional performance issues in Latin America.Company Guidance
Revenue Growth and New Customer Acquisitions
Total revenue grew 16% year-over-year, with a 20% increase excluding BioPharma. The company signed a record 35 new customers in Q2, bringing the total to 63 new customers for the year.
Partnership with AstraZeneca
SOPHiA GENETICS signed the largest contract in its history with AstraZeneca, focusing on AI-powered predictive models and real-world evidence generation for breast cancer treatment.
U.S. Market Expansion
U.S. revenue, excluding BioPharma, grew more than 19% year-over-year. Notable new customers include UC Irvine and the University of Alabama, Birmingham.
Strong Performance in Asia Pacific
Asia Pacific region saw a 33% year-over-year revenue growth with significant contributions from markets like Australia and India.
Improved Gross Margin and Cash Burn
Adjusted gross margin improved to 74.4%, up 120 basis points year-over-year. Cash burn was reduced by 35% year-over-year, to $8.7 million.
SOPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SOPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2025 | $3.30 | $3.42 | +3.64% |
May 06, 2025 | $3.14 | $3.00 | -4.46% |
Mar 04, 2025 | $3.57 | $3.10 | -13.17% |
Nov 05, 2024 | $3.75 | $3.75 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does SOPHiA GENETICS (SOPH) report earnings?
SOPHiA GENETICS (SOPH) is schdueled to report earning on Nov 11, 2025, Before Open (Confirmed).
What is SOPHiA GENETICS (SOPH) earnings time?
SOPHiA GENETICS (SOPH) earnings time is at Nov 11, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SOPH EPS forecast?
SOPH EPS forecast for the fiscal quarter 2025 (Q3) is -0.23.